The number of attacks by animal rights extremists saw a significant fall in 2005, with new laws introduced during the …
Europe's medicines regulator has approved Sandoz's Omnitrope, the world's first generic equivalent or 'biosimilar' of an existing biotech drug.Patents on …
Merck says that it will conduct a vigorous defence in the lawsuit brought by the family of Leonel Garza, who …
Health secretary Patricia Hewitt has unveiled the strategic and financial framework for the NHS in 2006/7, re-stating the government's pledge …
The UK biotech company which discovered rheumatoid arthritis drug Humira has hailed its success after sales passed the $1 billion …
Japanese pharma company Eisai is to open a major new single site facility in the UK, marking the country out …
Amgen, the world's largest biotechnology company is to open a new drug development centre in Uxbridge, London, as part of …
In the pharma industry personnel development seems to be viewed from a short-term perspective. Where personnel development is undertaken, process …
Patient groups have expressed disappointment at NICE plans to allow only some patients with Alzheimer's disease to have drug treatment, …
Roche and Amira Pharmaceuticals have entered into a new and unorthodox drug discovery and development partnership which will see them …
Health service leaders have warned that planned mergers of Primary Care Trusts in England will create larger bodies more remote …
Wyeth has submitted its new antidepressant desvenlafaxine to the FDA, a drug it hopes will be a successor to its …
Next generation hypertension drug aliskiren is on track for filing in late 2006 and is showing promising results in the …
The UK pharmaceutical industry's newly re-drafted code of conduct is to benefit from a PR campaign to promote awareness of …
Novartis has signed a deal with Belgium biotech Ablynx to develop the next generation of monoclonal antibodies with clinical development …
The FDA has unveiled plans to allow more small-scale exploratory studies of drugs in humans before formal phase I studies …
Novartis says it will appeal against an EMEA decision not to recommend its irritable bowel syndrome drug Zelnorm. Zelnorm (tegaserod) …
Patient groups and manufacturers are hoping NICE will reverse its decision to deny access to Alzheimer's drugs on the NHS, …
Schering-Plough expects its arthritis treatment Remicade to receive European approval to treat ulcerative colitis in early 2006.If approved Remicade (infliximab) …
Roche will equip its Central and Eastern European salesforces with StayinFront customer relationship management software after expanding its current contract …